Subscribe →
← All content Health & Medicine

The Confusion Behind Fecal Microbial Transplants in Cancer Treatment

Feb 24, 2026 · 7K views · 721 likes · 11 comments · 15 shares

Video link

AI Search Summary

This video is a science-communication critique about fecal microbiota transplants, or FMTs, in cancer treatment. The creator explains that an article linked the wrong Nature kidney-cancer study and that even the correct study did not prove FMTs eliminated immunotherapy side effects; it was an early phase-one study focused on safety, with interesting but correlational signals around bacterial engraftment and fewer severe immune-related adverse events.

  • Main question: How accurate are the claims about fecal microbial transplants in cancer treatment?
  • Short answer / core takeaway: The FMT cancer-treatment results are exciting, but the claim that toxic side effects could be eliminated is stronger than the evidence supports.
  • Evidence type: Science-news audit, press-release critique, phase-one study interpretation, and early clinical-trial context.
  • Search topics: fecal microbiota transplant cancer immunotherapy, FMT kidney cancer, immune-related adverse events, microbiome engraftment, cancer treatment press release exaggeration.

Common Search Questions

Did fecal microbiota transplants eliminate cancer immunotherapy side effects?

No. According to the transcript, the correct study was a phase-one study without a control group and did not prove that FMTs eliminated toxic side effects from immunotherapy.

What mistake did the article make?

The article linked to the wrong Nature kidney-cancer FMT study. That made the press-release claim appear to point to data showing a different pattern than the article described.

What was actually interesting about the study?

The interesting signal was that patients whose transplanted microbes seemed to engraft were also the people with fewer severe immune-related adverse events, but the video emphasizes that this is correlation and may reflect underlying patient health rather than direct causation.

Key Takeaways

  • The article discussed fecal microbiota transplants for cancer but linked to the wrong related kidney-cancer study.
  • Even after checking the correct study, the creator argues that the press-release language overstated what the evidence showed.
  • The correct study was described as a phase-one safety study, not a controlled test proving that FMTs reduce toxicity.
  • About 50% of patients still experienced bad side effects to immunotherapy, which the creator says was close to the expected normal rate.
  • Fewer severe toxicities appeared among immunotherapy responders, but this association does not establish causation.
  • The creator still describes the broader FMT cancer-treatment data as exciting and worth covering in a follow-up video.

Transcript

Why science education can be difficult

I have a confession to make, and it comes with a bit of a behind-the-scenes look into why making science education content feels like such an uphill battle.

So yesterday I was in the middle of filming a video, which means setting up my fancy camera, lighting, outfit, etc. And when I finished, I decided, hey, I’m already set up to film, why don’t I film another quick video about some new studies that I just read about?

The press release and article

I had seen this article about using poop pills to treat cancer. And it was just a word-for-word copy of a new press release about two new studies.

The studies were published in Nature, one of the top journals in the world, and the press release contained quotes from the original study authors. So I went ahead and filmed the very high-level video about just a press release in the quotes.

The rule: read the actual study

But then, I have a personal rule that I’ll never publish a video about a study without reading the actual study. And I like using direct quotes and figures taken from the text.

So the next day I was in the middle of editing and looking for key quotes and images that I could use in the video. And at first I was very confused.

The linked study did not match the claim

The article was about using fecal microbial transplants to improve cancer treatment. And it said that the first study could be eliminated with FMT, Thucle Matter Transplant.

And then a quote from the author about how normal immunotherapy can have very bad side effects leading to stopping the treatment early, which leads to bad outcomes. And how they were trying to fix that with FMTs. All pooper, I mean super.

Except when I looked at the linked study, it actually showed more side effects in the group receiving the FMT than the control group. But also better long-term results, meaning the study was showing something completely different than what they said.

The article linked the wrong study

I was confused. Until I realized that the article linked to the wrong study. Two studies published on using FMTs to help treat kidney cancer both on January 28, 26. Both published in Nature.

And while the original press release linked to the correct one, this article got them mixed up.

Why the correct study still did not prove the headline claim

Problem solved? No, because even then, the correct study did not show that FMTs lowered side effects. It was a phase one study with no control group. It was just trying to and powered to show that the FMT process was safe and didn’t make things which it did.

But 50% of the patients still experienced bad side effects to the immunotherapy, which is pretty in keeping with what is the normal percentage.

Engraftment and correlation

What was interesting about the new study, though, is that it seemed like the people who actually had the fewer side effects were the ones for whom the bacteria from the FMT actually seemed to take root, called engraftment.

But that’s correlation. It could be that the already healthier people were the ones who were more likely for that bacteria to be able to take root and have fewer immunotherapy, not that one causes the other.

The science-communication takeaway

So even when looking at the correct study, the official press releases statement that first study shows that the toxic side effects of drugs to treat kidney cancer could be eliminated with FMT, well, that’s a gross exaggeration of the data, which is so unnecessary because the actual data from all three studies is actually super exciting, which I’ll get to in the next video.

Additional Notes

Caption context

The caption frames the video as a critique of overexcited interpretation: the creator says extrapolating beyond the data can lower trust in science even when the underlying results are exciting.

FMT capsule method

The caption notes that one practical challenge with FMTs is getting the right bacteria into the small intestine. The studies used concentrated donor bacteria placed into tasteless, odorless, acid-resistant capsules designed to survive the stomach. The capsule product is named LND101 in the source data.

In the study described by the caption, the full dose comprised 36 to 40 capsules, or about 80 to 100 grams of stool, followed by two half-doses of 20 to 25 capsules each, or about 50 to 60 grams of stool.

Response-rate and toxicity notes

The caption notes that a 50% response rate to immunotherapy means the tumor is shrinking by a defined amount. It also says severe toxicity was much less common among immunotherapy responders than non-responders:

  • Responders with grade 3 immune-related adverse events: 1 of 9, or 11%.
  • Non-responders with grade 3 immune-related adverse events: 8 of 9, or 89%.
  • Reported association test: chi-squared = 8.00, P = 0.005.
  • Only 15 of 20 participants finished all planned FMT doses.

irAE means immune-related adverse event.

Keywords and topics

  • Fecal microbiota transplant and cancer
  • FMT capsules and LND101
  • Kidney cancer immunotherapy
  • Immune-related adverse events
  • Engraftment and correlation versus causation
  • Science press release accuracy
  • Hashtags: #science, #sciencenews, #tiktoklearningcampaign

References